After observing that TRAIL increases M1 macrophage cytotoxicity against tumor cells, the effect of TRAIL on the clinical outcome of cancer patients was investigated by analyzing KM plotter and cBioPortal databases. This evidence concerns the gene TNFSF10 and neoplasm.